🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2017-06-12
Trial ID
NCT03160885
Treatments Being Tested
The aim of the study is to evaluate the efficacy and safety of tralokinumab...
Status
Completed
Location
Research Site
Start Date
2015-01-23
Trial ID
NCT02347176
Treatments Being Tested
The purpose of this trial is to evaluate the efficacy and safety of traloki...
Status
Completed
Location
LEO Pharma Investigator
Start Date
2022-01-13
Trial ID
NCT05194540
Treatments Being Tested
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-05-30
Trial ID
NCT03131648
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Celerion
Start Date
2014-03-19
Trial ID
NCT02085473
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo C...
Status
Completed
Location
Research Site
Start Date
2014-06-13
Trial ID
NCT02161757
Treatments Being Tested
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled...
Status
Completed
Location
Research Site
Start Date
2015-02-19
Trial ID
NCT02281357
Treatments Being Tested
To assess the safety of the administration of the drug (CAT-354) in healthy...
Status
Completed
Location
Research Site
Start Date
2010-04
Trial ID
NCT01093040
The purpose of this trial is to test whether treatment with tralokinumab (a...
Status
Recruiting
Location
Leo Pharma Investigational site
Start Date
2024-06-10
Trial ID
NCT06311682
Treatments Being Tested